For medical abortion at < 12 weeks (using the combination of mifepristone plus misoprostol or using misoprostol alone): Recommend the option of self-management of the medical abortion process in whole or any of the three component parts of the process: self-assessment of eligibility (determining pregnancy duration; ruling out contraindications); self-administration of abortion medicines outside of a health-care facility and without the direct supervision of a trained health worker, and management of the abortion process; self-assessment of the success of the abortion